InvestSMART

Osteopore Limited (ASX: OSX) - Announcements

- Current share price for OSX : $0.003

ASX company news and announcements for Osteopore Limited (OSX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Osteopore Limited (OSX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Osteopore Limited (OSX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Osteopore Limited (OSX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$2 Notification regarding unquoted securities - OSX 6 Feb 2026 6:52PM $0.009 $0.003 fallen by 66.67%
$2 Cleansing Notice 6 Feb 2026 6:47PM $0.009 $0.003 fallen by 66.67%
$2 Further Drawdown of T1 of the Redeemable Convertible Notes 6 Feb 2026 6:45PM $0.009 $0.003 fallen by 66.67%
$2 Change in substantial holding 4 Feb 2026 7:36PM $0.011 $0.003 fallen by 72.73%
$2 Application for quotation of securities - OSX 3 Feb 2026 6:07PM $0.012 $0.003 fallen by 75%
$2 Ceasing to be a substantial holder 30 Jan 2026 7:47PM $0.015 $0.003 fallen by 80%
$2 Activities Report December 2025 and Appendix 4C 30 Jan 2026 9:25AM $0.015 $0.003 fallen by 80%
$2 OSX bolsters digital design, eyes HK Centre of Excellence 30 Jan 2026 9:22AM $0.015 $0.003 fallen by 80%
$2 Change in substantial holding 29 Jan 2026 7:17PM $0.015 $0.003 fallen by 80%
$2 Becoming a substantial holder 28 Jan 2026 7:54PM $0.016 $0.003 fallen by 81.25%
$2 Application for quotation of securities - OSX 27 Jan 2026 7:35PM $0.015 $0.003 fallen by 80%
$2 Change in substantial holding 23 Jan 2026 6:02PM $0.020 $0.003 fallen by 85%
$2 Clarification - agreement for orthopaedic products in HK 22 Jan 2026 5:24PM $0.026 $0.003 fallen by 88.46%
$2 OSX strikes agreement for orthopaedic products in Hong Kong 22 Jan 2026 9:21AM $0.020 $0.003 fallen by 85%
$2 Becoming a substantial holder 21 Jan 2026 9:25AM $0.013 $0.003 fallen by 76.92%
$2 Application for quotation of securities - OSX 20 Jan 2026 6:35PM $0.013 $0.003 fallen by 76.92%
$2 Application for quotation of securities - OSX 19 Jan 2026 1:07PM $0.012 $0.003 fallen by 75%
$2 Clarification - OSX partner Chinese dental & maxillofacial 16 Jan 2026 2:48PM $0.013 $0.003 fallen by 76.92%
$2 OSX partners up for Chinese dental & maxillofacial market 16 Jan 2026 8:20AM $0.007 $0.003 fallen by 57.14%
$2 Notification regarding unquoted securities - OSX 14 Jan 2026 7:17PM $0.008 $0.003 fallen by 62.50%
$2 Cleansing Notice - Convertible Notes 14 Jan 2026 7:15PM $0.008 $0.003 fallen by 62.50%
$2 Further Drawdown of T1 of the Redeemable Convertible Notes 14 Jan 2026 7:13PM $0.008 $0.003 fallen by 62.50%
$2 Application for quotation of securities - OSX 9 Jan 2026 4:38PM $0.011 $0.003 fallen by 72.73%
$2 OSX sign exclusive license for novel regenerative technology 8 Jan 2026 9:19AM $0.006 $0.003 fallen by 50%
$2 Ceasing to be a substantial holder 31 Dec 2025 9:20AM $0.006 $0.003 fallen by 50%

76 - 100 of 518 results

Page 4 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.